Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 339articles · 30d
- 2+ day agolatest article
- Aug 17, 2026earliest in window
- 92%with images
- 291avg words
- Economy, Business & Finance 195
- Health & Wellness 158
- Medical 157
- Business & Industrial 142
- Finance & Business 132
- Health 74
- Science & Technology 53
- Science & Nature 34
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
NYU Langone Health's Perlmutter Cancer Center Appoints New Vice Chair of Physics and Dosimetry in the Department of Radiation Oncology
2+ day, 13+ hour ago (183+ words) NEW YORK, Sept. 10, 2026 /PRNewswire/ -- NYU Langone Health's Perlmutter Cancer Center has appointed Sean L. Berry, PhD, as vice chair of physics and dosimetry in the Department of Radiation Oncology. Dr. Berry brings more than 20 years of experience in radiation oncology physics,…...
TAE Life Sciences Achieves ISO 13485 Certification, Marking a Major Milestone in Quality and Regulatory Excellence
2+ day, 13+ hour ago (137+ words) Audit Concluded with Zero Findings, Underscoring the Company's Commitment to Patient Safety and Medical Device Quality A Defining Milestone for TAE Life Sciences The certification was awarded following a comprehensive audit conducted by BSI (British Standards Institution), a globally recognized…...
IMDS Launches NHanceIT™ Microcatheter in the U.S. to Advance Complex PCI
2+ day, 13+ hour ago (211+ words) Proprietary Skeleton Backbone™ technology introduces a new approach to catheter design to address the growing complexity in coronary interventions Powered by proprietary Skeleton Backbone technology, NHanceIT maintains force transmission from hub to distal end. True 1:1 torque response and reinforced metal…...
Three Life-Saving Medical Technologies Named Finalists for the Second Annual Thomas J. Fogarty Innovation Prize
2+ day, 13+ hour ago (335+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...
NEURELIS CEO CRAIG CHAMBLISS TO PRESENT KEYNOTE AT THE 14TH ANNUAL OUTSOURCING IN CLINICAL TRIALS SOUTHERN CALIFORNIA 2026 CONFERENCE
2+ day, 14+ hour ago (319+ words) SAN DIEGO, Sept. 10, 2026 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced its Founder and Chief Executive Officer Craig Chambliss will give a keynote address at the 14th Annual Outsourcing Clinical Trials (OCT) Southern California 2026 conference, to be…...
Incyte Announces Funding of MINJUVI® (tafasitamab) for patients with Relapsed or Refractory Follicular Lymphoma through Ontario's FAST Program
2+ day, 14+ hour ago (346+ words) Despite advances in care, most patients with FL eventually experience relapse, highlighting the need for additional treatment options across multiple lines of therapy.3 The acceptance of cancer therapies such as MINJUVI® in the treatment of FL represents a significant step,…...
Olympus Announces New Class of iTind™ Center of Excellence Program Physicians
2+ day, 14+ hour ago (457+ words) Program Aims to Advance Minimally Invasive Treatment of Enlarged Prostate CENTER VALLEY, Pa., Sept. 10, 2026 /PRNewswire/ -- Olympus Corp. of the Americas (Olympus) is pleased to announce the newest members of the iTind™ Center of Excellence (COE) Program, which is designed to…...
Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline
3+ day, 5+ hour ago (429+ words) BioSpace Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline CAMBRIDGE, England--(BUSINESS WIRE)--Clinical-stage biotech Alchemab Therapeutics has appointed experienced pharma and biotech leader Dr Ben Porter-Brown as Chief…...
Bionyra Pharma Announces First Healthy Volunteers Dosed in Phase 1 Study of BYN-001, a Long-Acting IL-25 Antibody for Atopic Dermatitis
3+ day, 35+ min ago (424+ words) BioSpace Bionyra Pharma Announces First Healthy Volunteers Dosed in Phase 1 Study of BYN-001, a Long-Acting IL-25 Antibody for Atopic Dermatitis - BYN-001 targets IL-25, an emerging upstream regulator of Type 2 inflammation implicated in atopic dermatitis, and leverages half-life extension technology - Bionyra is building…...
Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs
3+ day, 1+ hour ago (140+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...